Compliance with Opioid Treatment Guidelines for Chronic Non-Cancer Pain (CNCP) in Primary Care at a Veterans Affairs Medical Center (VAMC)

Pain Medicine (United States)

Volumn 14, Issue 10, 2013, Pages 1548-1556

  Sekhon, Ripple ^a   Aminjavahery, Noushin ^b   Davis, Charles N ^a   Roswarski, Mary Jayne ^a   Robinette, Camille ^a  

^a WG (Bill) Hefner Medical Center   (United States)

^b VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

Aberrant; Non Cancer; Opioid; Pain; Prescribing; Primary Care

Indexed keywords

MORPHINE; OXYCODONE;

ABDOMINAL PAIN; ADULT; AGED; ANALGESIA; ARTICLE; CHRONIC PAIN; COMORBIDITY; FEMALE; FIBROMYALGIA; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NECK PAIN; OSTEOARTHRITIS; PHANTOM PAIN; POSTTRAUMATIC STRESS DISORDER; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; PROTOCOL COMPLIANCE; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; SUBSTANCE ABUSE; TREATMENT DURATION;

ABERRANT; NON-CANCER; OPIOID; PAIN; PRESCRIBING; PRIMARY CARE;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CHRONIC PAIN; FEMALE; GUIDELINE ADHERENCE; HOSPITALS, VETERANS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84885856794     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12164     Document Type: Article

References (43)

1. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain 2004;109:514-519.
2. Cherry DK, Woodwell DA, Rechtsteiner EA. National Ambulatory Medical Care Survey: 2005 summary. Adv Data 2007;387:1-39. [PMID: 17703793].
3. Clark JD. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage 2002;23:131-137.
4. Elliott AM, Smith BH, Penny KI, Smith WC, Chambers WA. The epidemiology of chronic pain in the community. Lancet 1999;354:1248-1252.
5. The Management of Opioid Therapy for Chronic Pain Working Group. VA/DoD clinical practice guideline for the management of opioid therapy for chronic pain. Version 2.0. Washington, DC: Veterans Health Administration and Department of Defense. 2010.
6. Chou R, Fanciullo GJ, Fine PG, etal. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10(2):113-130.
7. Martell BA, O'Connor PG, Kerns RD. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Ann Intern Med 2007;146(2):116-127.
8. Trescot AM, Helm S, Hanson H, etal. Opioid in the management of chronic non-cancer pain: An update of American Society of the Interventional Pain Physicians' (ASIPP) guidelines. Pain Physician 2008;Opioid Special Issue: 11:S5-S62.
9. Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States 1999-2006. Center for Disease Control and Prevention. No.22, Sep 2009.
10. Haddox JD, Joranson D, Angarola RT, etal. The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997;13(1):6-8.
11. Federation of State Medical Boards of the United States. Model policy for the use of controlled substances for the treatment of pain. 2004. Available at: http://www.fsmb.org/pdf/2004_grpol_Controlled_Substances.pdf (accessed August 2010).
12. Washington State Agency Medical Directors' Group. Interagency guideline on opioid dosing for chronic non-cancer pain: An educational aid to improve care and safety with opioid therapy 2010 Update. Available at: http://www.agencymeddirectors.wa.gov/guidelines.asp (accessed August 2010).
13. Bhamb B, Brown D, Hariharan J, etal. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin 2006;22:1859-6525.
14. Hariharan J, Lamb GC, Neuner JM. Long-term opioid contract use for chronic pain management in primary care practice. A five year experience. J Gen Intern Med 2007;22:485-490.
15. Penko J, Mattson J, Miaskowski C, Kushel M. Do patients know they are on pain medication agreements? Results from a sample of high risk patients on chronic opioid therapy. Pain Med 2012;13(9):1174-1180.
16. Wu PC, Lang C, Hasson NK, Linder SH, Clark DJ. Opioid use in young veterans. J Opioid Manag 2010;6(2):133-139.
17. Bohnert AS, Valenstein M, Blair MJ, etal. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011;305(13):1315-1321.
18. Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis. Clin J Pain 2008;24(6):497-508.
19. Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine. A rational approach to the treatment of chronic pain. Pain Med 2005;6(2):107-112.
20. Adams NJ, Plane MB, Fleming MF, etal. Opioids and the treatment of chronic pain in a primary care sample. J Pain Symptom Manage 2001;22(3):791-796.
21. Boulanger A, Clark AJ, Squire P, Cui E, Horbay GL. Chronic pain in Canada: Have we improved our management of chronic noncancer pain? Pain Res Manag 2007;12:39-47. [PMID: 17372633].
22. Starrels JL, Becker WC, Alford DP. Systematic review: Treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med 2010;152(11):712-720.
23. Starrels JL, Becker WC, Weiner MG, etal. Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. J Gen Intern Med 2011;26(9):958-964.
24. Morasco BJ, Duckart JP, Dobscha SK. Adherence to clinical guidelines for opioid therapy for chronic pain patients with substance use disorder. J Gen Intern Med 2011;26(9):965-971.
25. Manchikanti L, Manchukonda R, Damron KS. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician 2006;9(1):57-60.
26. Reisfield GM, Salazar E, Bertholf RL. Rational use and interpretation of urine drug testing in chronic opioid therapy. Ann Clin Lab Sci 2007;37(4):301-314.
27. Floete OG. Urinary drug testing in pain management. Practical Pain Management. April 2005.
28. Melanson SE, Kredlow MI, Jarolim P. Analysis and interpretation of drug testing results from patients on chronic pain therapy: A clinical laboratory perspective. Clin Chem Lab Med 2009;47(8):971-976.
29. Starrels JL, Fox AD, Kunins HV, Cuningham CO. They don't know what they don't know: Internal medicine residents' knowledge and confidence in urine drug test interpretation for patients with chronic pain. J Gen Intern Med 2012;11:1521-1527.
30. Clark J. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage 2002;23(2):131-137.
31. Reid MC, Engles-Horton LL, Weber MB, etal. Use of opioid medications for chronic noncancer pain syndrome in primary care. J Gen Intern Med 2002;17(3):173-179.
32. Barett JE, Barett JA, Oxman TE. The prevalence of psychiatric disorders in a primary care practice. Arch Gen Psychiatry 1988;45(12):1100-1106.
33. Katon W, Schulberg H. Epidemiology of depression in primary care. Gen Hosp Psychiatry 1992;14(4):237-247.
34. Ives TJ, Chelminski PR, Hammett-Stabler CA, etal. Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Serv Res 2006;6:46.
35. Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 2007;129:355-362.
36. Dennis TC, Kimberly SS, Robert GJ. Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis. Clin J Pain 2008;24(6):497-508.
37. Manchikanti L, Giordano J, Boswell MV, etal. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manag 2007;3(2)89-100.
38. Boscarino JA, Ruksralis M, Hoffman S, etal. Risk factors for drug dependence among patients on opioid therapy in a large us healthcare system. Addiction 2010;105:1776-1782.
39. Martin SS, Fenton MC, Keyes KM, etal. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid use disorder: Longitudinal evidence from national epidemiologic study on alcohol and related conditions. Psychol Med 2012;42(6):1261-1272.
40. Gomes T, Mamdani MM, Dhalla IA. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 2011;171(7):686-691.
41. Dunn KM, Saunders KW, Rutter CM. Opioid prescriptions for chronic pain and overdose. Ann Intern Med 2010;152:85-92.
42. White AG, Birnbaum HG, Schiller M, Tang J, Katz NP. Analytic models to identify patients at risk for prescription opioid abuse. Am J Manag Care 2009;15(12):897-906.
43. Franklin GM, Mai J, Wichizer T, etal. Opioid dosing trends and mortality in Washington state workers' compensation, 1996-2002. Am J Ind Med 2005;48:91-99.